|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robadi IA, Pharaon M and Ducatman BS: The
importance of high-risk human papillomavirus types other than 16
and 18 in cervical neoplasia. Arch Pathol Lab Med. 142:693–695.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Solís JG and Briones-Torres TI: Prevalence
of intraepithelial lesion in cervical screening cytology in a
First-level Care Unit. Rev Med Inst Mex Seguro Soc. 56:167–172.
2018.(In Spanish; Abstract available in Spanish from the
publisher). PubMed/NCBI
|
|
4
|
Aruga J, Yokota N, Hashimoto M, Furuichi
T, Fukuda M and Mikoshiba K: A novel zinc finger protein, zic, is
involved in neurogenesis, especially in the cell lineage of
cerebellar granule cells. J Neurochem. 63:1880–1890. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aruga J and Millen KJ: ZIC1 Function in
normal cerebellar development and human developmental pathology.
Adv Exp Med Biol. 1046:249–268. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verlaat W, Snijders PJF, Novianti PW,
Wilting SM, De Strooper LMA, Trooskens G, Vandersmissen J, Van
Criekinge W, Wisman GBA, Meijer CJLM, et al: Genome-wide DNA
methylation profiling reveals methylation markers associated with
3q gain for detection of cervical precancer and cancer. Clin Cancer
Res. 23:3813–3822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gan L, Chen S, Zhong J, Wang X, Lam EK,
Liu X, Zhang J, Zhou T, Yu J, Si J, et al: ZIC1 is downregulated
through promoter hypermethylation, and functions as a tumor
suppressor gene in colorectal cancer. PLoS One. 6:e169162011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han W, Zhang C, Gao XJ, Wang HB, Chen F,
Cao F, Hu YW, Ma J, Gu X and Ding HZ: Clinicopathologic and
prognostic significance of the zinc finger of the cerebellum family
in invasive breast cancer. J Breast Cancer. 21:51–61. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma G, Dai W, Sang A, Yang X and Li Q:
Roles of ZIC family genes in human gastric cancer. Int J Mol Med.
38:259–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS,
Chan SC, Ho TW, Wong KW, Yu MY, Wang VW, et al: Identification of
molecular markers and signaling pathway in endometrial cancer in
Hong Kong Chinese women by genome-wide gene expression profiling.
Oncogene. 26:1971–1982. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu X, Liu Q, Yang N, Shen JF, Zhang XG,
Cao F and Ding HZ: Clinicopathological significance of increased
ZIC1 expression in human endometrial cancer. J Huazhong Univ Sci
Technolog Med Sci. 35:898–903. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim S, Cho K, Lee S, Lee K, Shin J, Chung
D and Park C: Effect of number of retrieved lymph nodes on
prognosis in FIGO stage IB-IIA cervical cancer patients treated
with primary radical surgery. J Obstet Gynaecol Res. 43:211–219.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ginocchio CC, Barth D and Zhang F:
Comparison of the Third Wave Invader human papillomavirus (HPV)
assay and the digene HPV hybrid capture 2 assay for detection of
high-risk HPV DNA. J Clin Microbiol. 46:1641–1646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guevara A, Cabello R, Woelber L, Moreira
ED Jr, Joura E, Reich O, Shields C, Ellison MC, Joshi A and
Luxembourg A: Antibody persistence and evidence of immune memory at
5years following administration of the 9-valent HPV vaccine.
Vaccine. 35:5050–5057. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martínez-Lavín M and Amezcua-Guerra L:
Serious adverse events after HPV vaccination: A critical review of
randomized trials and post-marketing case series. Clin Rheumatol.
36:2169–2178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang F, Munck J, Tang J, Taverna P, Wang
Y, Miller DF, Pilrose J, Choy G, Azab M, Pawelczak KS, et al: The
novel, small-molecule DNA methylation inhibitor SGI-110 as an
ovarian cancer chemosensitizer. Clin Cancer Res. 20:6504–6516.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du L, Qian X, Dai C, Wang L, Huang D, Wang
S and Shen X: Screening the molecular targets of ovarian cancer
based on bioinformatics analysis. Tumori. 101:384–389. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiang W, Zhao Y, Yang Q, Liu W, Guan H, Lv
S, Ji M, Shi B and Hou P: ZIC1 is a putative tumor suppressor in
thyroid cancer by modulating major signaling pathways and
transcription factor FOXO3a. J Clin Endocrinol Metab.
99:E1163–E1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Lin Z, Xue M, Si J and Chen S:
Zic1 promoter hypermethylation in plasma DNA is a potential
biomarker for gastric cancer and intraepithelial neoplasia. PLoS
One. 10:e01339062015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van der Zee RP, Richel O, van Noesel CJM,
Novianti PW, Ciocanea-Teodorescu I, van Splunter AP, Duin S, van
den Berk GEL, Meijer CJLM, Quint WGV, et al: Host cell
deoxyribonucleic acid methylation markers for the detection of
high-grade anal intraepithelial neoplasia and anal cancer. Clin
Infect Dis. 68:1110–1117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baribault C, Ehrlich KC, Ponnaluri VKC,
Pradhan S, Lacey M and Ehrlich M: Developmentally linked human DNA
hypermethylation is associated with down-modulation, repression,
and upregulation of transcription. Epigenetics. 13:275–289. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han W, Cao F, Gao XJ, Wang HB, Chen F, Cai
SJ, Zhang C, Hu YW, Ma J, Gu X and Ding HZ: ZIC1 acts a tumor
suppressor in breast cancer by targeting survivin. Int J Oncol.
53:937–948. 2018.PubMed/NCBI
|
